<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">MD-Onco</journal-id><journal-title-group><journal-title xml:lang="en">MD-Onco</journal-title><trans-title-group xml:lang="ru"><trans-title>MD-Onco</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2782-3202</issn><issn publication-format="electronic">2782-6171</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">211</article-id><article-id pub-id-type="doi">10.17650/2782-3202-2025-5-4-65-71</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>RARE NEOPLASMS AND COMPLEX CLINICAL SITUATIONS: DIFFICULTIES IN DIAGNOSIS AND SELECTION OF TREATMENT TACTICS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>РЕДКИЕ НОВООБРАЗОВАНИЯ И СЛОЖНЫЕ КЛИНИЧЕСКИЕ СИТУАЦИИ: ТРУДНОСТИ ДИАГНОСТИКИ И ВЫБОР ТАКТИКИ ЛЕЧЕНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Infantile hemangioma: from diagnosis to treatment. Literature review</article-title><trans-title-group xml:lang="ru"><trans-title>Инфантильная гемангиома: от диагностики до лечения. Обзор литературы</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3452-1560</contrib-id><name-alternatives><name xml:lang="en"><surname>Klyut</surname><given-names>Artem S.</given-names></name><name xml:lang="ru"><surname>Клют</surname><given-names>Артем Сергеевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>arteom.klyut@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7882-1317</contrib-id><name-alternatives><name xml:lang="en"><surname>Sergeenko</surname><given-names>E. Yu.</given-names></name><name xml:lang="ru"><surname>Сергеенко</surname><given-names>Е. Ю.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>arteom.klyut@yandex.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7574-335X</contrib-id><name-alternatives><name xml:lang="en"><surname>Kharbediya</surname><given-names>V. Kh.</given-names></name><name xml:lang="ru"><surname>Харбедия</surname><given-names>В. Х.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>arteom.klyut@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2397-3484</contrib-id><name-alternatives><name xml:lang="en"><surname>Glazyrina</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Глазырина</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>arteom.klyut@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8520-2378</contrib-id><name-alternatives><name xml:lang="en"><surname>Petryaykina</surname><given-names>E. E.</given-names></name><name xml:lang="ru"><surname>Петряйкина</surname><given-names>Е. Е.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>arteom.klyut@yandex.ru</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Federal Children’s Rehabilitation Center “Korablik” – structural division of the Russian Children’s Clinical Hospital – branch of the N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">Федеральный детский реабилитационный центр «Кораблик» – структурное подразделение Российской детской клинической больницы – филиала ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Russian Children’s Clinical Hospital – branch of the N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">Российская детская клиническая больница – филиал ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2025-12-17" publication-format="electronic"><day>17</day><month>12</month><year>2025</year></pub-date><volume>5</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>65</fpage><lpage>71</lpage><history><date date-type="received" iso-8601-date="2025-12-17"><day>17</day><month>12</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-12-17"><day>17</day><month>12</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, Klyut A.S., Sergeenko E.Y., Kharbediya V.K., Glazyrina A.A., Petryaykina E.E.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, Клют А.С., Сергеенко Е.Ю., Харбедия В.Х., Глазырина А.А., Петряйкина Е.Е.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">Klyut A.S., Sergeenko E.Y., Kharbediya V.K., Glazyrina A.A., Petryaykina E.E.</copyright-holder><copyright-holder xml:lang="ru">Клют А.С., Сергеенко Е.Ю., Харбедия В.Х., Глазырина А.А., Петряйкина Е.Е.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://mdonco.abvpress.ru/jour/article/view/211">https://mdonco.abvpress.ru/jour/article/view/211</self-uri><abstract xml:lang="en"><p>Infantile hemangioma or infantile vascular malformation is a benign vascular neoplasm that occurs as a result of abnormal proliferation of endothelial cells with disturbed blood vessel architecture.</p> <p>This article provides a current review of the literature, information on the classification of infantile hemangioma, etiology, diagnosis, and treatment.</p></abstract><trans-abstract xml:lang="ru"><p>Инфантильная, или младенческая, гемангиома – доброкачественное сосудистое новообразование, которое возникает в результате аномальной пролиферации эндотелиальных клеток с нарушенной архитектоникой кровеносных сосудов.</p> <p>В статье представлены современный обзор литературы, информация о классификации инфантильной гемангиомы, этиологии, диагностике и лечении.</p></trans-abstract><kwd-group xml:lang="en"><kwd>infantile hemangioma</kwd><kwd>infantile vascular neoplasm</kwd><kwd>neoplasm</kwd><kwd>hemangioma</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>инфантильная гемангиома</kwd><kwd>младенческая гемангиома</kwd><kwd>сосудистое новообразование</kwd><kwd>новообразование</kwd><kwd>гемангиома</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Nazemian S., Sharif S., Childers E.L.B. Infantile hemangioma: a common lesion in a vulnerable population. Int J Environ Res Public Health 2023;20(8):5585. DOI: 10.3390/ijerph20085585</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Holm A., Mulliken J.B., Bischoff J. Infantile hemangioma: the common and enigmatic vascular tumor. J Clin Invest 2024;134(8):e172836. DOI: 10.1172/JCI172836</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Ding Y., Zhang J.Z., Yu S.R. et al. Risk factors for infantile hemangioma: a meta-analysis. World J Pediatr 2020;16(4):377–84. DOI: 10.1007/s12519-019-00327-2</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Xu W., Zhao H. Management of infantile hemangiomas: recent advances. Front Oncol 2022;12:1064048. DOI: 10.3389/fonc.2022.1064048</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Tiemann L., Hein S. Infantile hemangioma: a review of current pharmacotherapy treatment and practice pearls. J Pediatr Pharmacol Ther 2020;25(7):586–99. DOI: 10.5863/1551-6776-25.7.586</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Sandru F., Turenschi A., Constantin A.T. et al. Infantile hemangioma: a cross-sectional observational study. Life (Basel) 2023;13(9):1868. DOI: 10.3390/life13091868</mixed-citation></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Ministry of Health of Russia. Infantile hemangioma. Clinical recommendations. 2023. Available at: https://cr.minzdrav.gov.ru/schema/769_1 (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Министерство здравоохранения Российской федерации. Гемангиома инфантильная. Клинические рекомендации. 2023. Доступно по: https://cr.minzdrav.gov.ru/schema/769_1</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><mixed-citation>Matić A., Matić M., Prćić S. et al. Multifocal infantile hemangioma – presentation of 4 cases and review of the selected literature. Acta Dermatovenerol Croat 2023;31(4):208–12.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Xia M., Liu W., Hou F. Mast cell in infantile hemangioma. Front Oncol 2024;14:1304478. DOI: 10.3389/fonc.2024.1304478</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Xiang S., Gong X., Qiu T. et al. Insights into the mechanisms of angiogenesis in infantile hemangioma. Biomed Pharmacother 2024;178:117181. DOI: 10.1016/j.biopha.2024.117181</mixed-citation></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Khachatryan L.A., Kletskaya I.S. Infantile hemangioma explained in simple terms. Voprosy gemtologii/onkologii i immunologii v pediatrii = Pediatric Hematology/Oncology and Immunopathology 2021;20(1):192–206. (In Russ.). DOI: 10.24287/1726-1708-2021-20-1-192-206</mixed-citation><mixed-citation xml:lang="ru">Хачатрян Л.А., Клецкая И.С. Просто о сложном: инфантильная гемангиома. Вопросы гематологии/онкологии и иммунопатологии в педиатрии 2021;20(1):192–206. DOI: 10.24287/1726-1708-2021-20-1-192-206</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><mixed-citation>Wildgruber M., Sadick M., Müller-Wille R., Wohlgemuth W.A. Vascular tumors in infants and adolescents. Insights Imaging 2019;10(1):30. DOI: 10.1186/s13244-019-0718-6</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Park M. Infantile hemangioma: timely diagnosis and treatment. Clin Exp Pediatr 2021;64(11):573–4. DOI: 10.3345/cep.2021.00752</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Chamli A., Litaiem N. PHACE syndrome. 2023. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Bellinato F., Marocchi M., Pecoraro L. et al. Diagnosis and treatment of infantile hemangioma from the primary care paediatricians to the specialist: a narrative review. Children (Basel) 2024;11(11):1397. DOI: 10.3390/children11111397</mixed-citation></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Turkiya L.R., Muftakhova G.M., Karmanova D.A. et al. Infantile hemangioma and diffuse hepatic hemangiomatosis in neonates with the development of life-threatening events. RMZH. Mat i ditya = Russian Journal of Woman and Child Health 2025;8(2):173–82 (In Russ.). DOI: 10.32364/2618-8430-2025-8-2-10</mixed-citation><mixed-citation xml:lang="ru">Туркия Л.Р., Муфтахова Г.М., Карманова Д.А. и др. Инфантильная гемангиома и диффузный гемангиоматоз печени у новорожденных с развитием жизнеугрожающих состояний. РМЖ. Мать и дитя 2025;8(2):173–82. DOI: 10.32364/2618-8430-2025-8-2-10</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><mixed-citation>Xu M.N., Zhang M., Xu Y. et al. Individualized treatment for infantile hemangioma. J Craniofac Surg 2018;29(7):1876–9. DOI: 10.1097/SCS.0000000000004745</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Tan X., Guo S., Wang C. Propranolol in the treatment of infantile hemangiomas. Clin Cosmet Investig Dermatol 2021;14:1155–63. DOI: 10.2147/CCID.S332625</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Pope E., Lara-Corrales I., Sibbald C. et al. Noninferiority and safety of nadolol vs propranolol in infants with infantile hemangioma. JAMA Pediatr 2022;176(1):34–41. DOI: 10.1001/jamapediatrics.2021.4565</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Ji Y., Chen S., Yang K. et al. Efficacy and safety of propranolol vs atenolol in infants with problematic infantile hemangiomas. JAMA Otolaryngol Head Neck Surg 2021;147(7):599–607. DOI: 10.1001/jamaoto.2021.0454.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Muñoz-Garza F.Z., Ríos M., Roé-Crespo E. et al. Efficacy and safety of topical timolol for the treatment of infantile hemangioma in the early proliferative stage: a randomized clinical trial. JAMA Dermatol 2021;157(5):583–7. DOI: 10.1001/jamadermatol.2021.0596</mixed-citation></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">Shervashidze M.A., Smirnova D.S., Valiev T.T. et al. Antileukemic impact of glucocorticoid use in acute lymphoblastic leukaemia treatment. Pediatricheskaya farmakologiya = Pediatric Pharmacology 2023;20(4):303–8. (In Russ.). DOI: 10.15690/pf.v20i4.2603</mixed-citation><mixed-citation xml:lang="ru">Шервашидзе М.А., Смирнова Д.С., Валиев Т.Т. и др. Антилейкемические эффекты глюкокортикоидов при лечении острого лимфобластного лейкоза. Педиатрическая фармакология 2023;20(4):303–8. DOI: 10.15690/pf.v20i4.2603</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">Belysheva T.S., Kotlukova N.P., Valiev T.T. et al. Results of infantile hemangioma laser therapy in children with persistent residual signs after systemic propranolol therapy: clinical cases. Voprosy sovremennoy pediatrii = Current Pediatrics 2021;20(5):418–25. (In Russ.). DOI: 10.15690/vsp.v20i5.2317</mixed-citation><mixed-citation xml:lang="ru">Белышева Т.С., Котлукова Н.П., Валиев Т.Т. и др. Результаты лазеротерапии младенческих гемангиом у детей со стойкими остаточными явлениями после системной терапии пропранололом: клинические случаи. Вопросы современной педиатрии 2021;20(5):418–25. DOI: 10.15690/vsp.v20i5.2317</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><mixed-citation>Chaple Gil A., Caviedes R., Díaz L. et al. Comparative evaluation of laser therapy for infantile hemangiomas: a systematic review of clinical outcomes and treatment considerations. Photodiagnosis Photodyn Ther 2025;53:104637. DOI: 10.1016/j.pdpdt.2025.104637</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Beqo B.P., Gasparella P., Flucher C. et al. Indications for surgical resection of complicated infantile hemangiomas in the β-blocker’s era: a single-institution experience from a retrospective cohort study. Int J Surg 2023;109(4):829–40. DOI: 10.1097/JS9.0000000000000324</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Lu W., Yang Z., Wang M. et al. Identification of potential therapeutics for infantile hemangioma via in silico investigation and in vitro validation. Drug Des Devel Ther 2024;18:4065–88. DOI: 10.2147/DDDT.S460575</mixed-citation></ref></ref-list></back></article>
